orderly tirzepatide FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price FDA says compounding pharmacies can

Mutat Res 333, 1019

So less is always going to be more when it comes to things like alcohol

2017 DOI: 10.1007/s40262-016-0501-5 PMID: 28063031 Minder EI, Barman-Aksoezen J, Schneider-Yin X

Adverse effects such as tachycardia, infections, headaches, dizziness, nausea, vomiting, diarrhea, and dyspepsia, as well as contraindications such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, hypersensitivity, severe gastrointestinal diseases, renal impairment, and pregnancy have been noted

If finalized, it would close the bulks-list pathway entirely for these three GLP-1 substances

It's well-tolerated and effective for the majority